A systems pharmacology approach to improve drug therapy in NSCLC: establishing a CESAR network

Int J Clin Pharmacol Ther. 2014 Jan;52(1):89-91. doi: 10.5414/CPXCES13EA07.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Cell Line, Tumor
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / physiology*
  • Humans
  • Lung Neoplasms / drug therapy*

Substances

  • ErbB Receptors